Zhitong Finance App News, Lepu Healthcare (300003.SZ) issued an announcement. The company learned today that the company's holding subsidiary Shanghai Minwei Biotechnology Co., Ltd. (“Shanghai Minwei Biotech”) has received the “Drug Clinical Trial Approval Notice” (Notice Number: 2026LP03439) approved and issued by the State Drug Administration, and the MWX205 injection clinical trial application declared by Shanghai Minwei Biology has been approved.

Zhitongcaijing · 6d ago
Zhitong Finance App News, Lepu Healthcare (300003.SZ) issued an announcement. The company learned today that the company's holding subsidiary Shanghai Minwei Biotechnology Co., Ltd. (“Shanghai Minwei Biotech”) has received the “Drug Clinical Trial Approval Notice” (Notice Number: 2026LP03439) approved and issued by the State Drug Administration, and the MWX205 injection clinical trial application declared by Shanghai Minwei Biology has been approved.